Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.

The present study was designed (a) to characterize the activity of loxiglumide as a peripheral cholecystokinin (CCK) antagonist in healthy human subjects, and (b) to determine whether CCK is a physiologic regulator of the intestinal phase of meal-stimulated exocrine pancreatic and biliary secretions...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autors principals:	Hildebrand, P, Beglinger, C, Gyr, K, Jansen, J B, Rovati, L C, Zuercher, M, Lamers, C B, Setnikar, I, Stalder, G A
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 1990
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296477/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2312719/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114486
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!